4Freundl G,Godtke K,Gnoth C,et al.Steroidal'add-back'therapy in patients treated with GnRH agonists[J].GynecolObstet Invest,1998,45(Suppl1):22.
5Sagsveen M,Farmer J,Prentice A.Gonadotrophin-releasing hormone analogues for endometriosis:bone mineral density[J].Cochrane Database Syst Rev,2003,(4):CD001297.
6Saito T,Yoshizawa M,Yamauchi Y,et al.Effects of the novel orally active antiestrogen TZE-5323 on experimental endometriosis.Arzneimittelforchung,2003,53(7):507.
7Soysal S,Soysal M E,Ozer S,et al.The effects of post-surgical administration of goserelin plus anastozole compared to gaserelin alone in patients with severe endometriosis:a prospective randomized trial[J].HumReprod,2004,19(1):160.
8Santen R J.Inhibition aromatase:insights fromrecent studies[J].Steroids,2003,68(7-8):559.
9Ebert A D,Bartley J,David M,et al.Aromatase inhibitors theoretical concept and present experiences in the treatment of endometriosis[J].Zentralbl Gynakol,2003,125(7-8):247.
10D′Hooghe T M,Kvama C,Debrock S,et al.Future directions in endometriosis research[J].Ann NYAcad Sci,2004,1034:316.
二级参考文献5
1David LO.Endometriosis in clinical practice.New York:Taylore Frances Group,2005.193-200.
2Tulandi T,Redwine D.Endometriosis.Advances and controversies.New York:Marce Dekker,2004.210-216.
3Redwine D.Surgical management of endometriosis.New York:Taylore Frances Group,2004.149-157.
